Carol Caesar
Impact in
- Oncology top 2%
- Lymphatic System and Diseases
- Cancer Cells and Metastasis
- Vascular Tumors and Angiosarcomas
- Molecular Biology top 5%
- Angiogenesis and VEGF in Cancer
Papers in ⓘ
- Oncology 14
- Lymphatic System and Diseases 14
- Cancer Cells and Metastasis 2
-
- Angiogenesis and VEGF in Cancer 13
- Co-authors
- Steven A. Stacker (14 shared papers)Marc G. Achen (12 shared papers)Megan E. Baldwin (3 shared papers)Richard A. Williams (1 shared paper)Shin‐Ichi Nishikawa (1 shared paper)Remko Prevo (1 shared paper)Hajime Kubo (1 shared paper)David G. Jackson (1 shared paper)
In The Last Decade
Carol Caesar
14 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Oncology 1.5k
- Molecular Biology 1.4k
- Cancer Research 263
- Cellular and Molecular Neuroscience 213
- Physiology 267
Countries citing papers authored by Carol Caesar
This map shows the geographic impact of Carol Caesar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Caesar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Caesar more than expected).
Fields of papers citing papers by Carol Caesar
This network shows the impact of papers produced by Carol Caesar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Caesar. The network helps show where Carol Caesar may publish in the future.
Co-authors
The 25 scholars most cited alongside Carol Caesar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | VEGF-D promotes the metastatic spread of tumor cells via the lymphatics Hit paper breakdown → | 2001 | 993 |
| 2 | 1999 | 269 | |
| 3 | 2012 | 224 | |
| 4 | 1999 | 218 | |
| 5 | 2000 | 94 | |
| 6 | 1999 | 93 | |
| 7 | 2003 | 60 | |
| 8 | 2019 | 39 | |
| 9 | 2013 | 34 | |
| 10 | 2012 | 26 | |
| 11 | 2006 | 16 | |
| 12 | 2000 | 14 | |
| 13 | 2016 | 6 | |
| 14 | 2017 | 3 |
About Carol Caesar
Carol Caesar is a scholar working on Oncology, Molecular Biology, Physiology, Surgery and Genetics, having authored 14 papers that have together received 2.1k indexed citations. Recurring topics across this work include Lymphatic System and Diseases (14 papers), Angiogenesis and VEGF in Cancer (13 papers), Sympathectomy and Hyperhidrosis Treatments (3 papers), Axon Guidance and Neuronal Signaling (2 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers), Cancer Cells and Metastasis (2 papers), Venous Thromboembolism Diagnosis and Management (1 paper) and Lymphatic Disorders and Treatments (1 paper). The work is most often cited by research in Oncology (1.5k citations), Molecular Biology (1.4k citations), Cancer Research (263 citations), Cellular and Molecular Neuroscience (213 citations) and Physiology (267 citations). Carol Caesar has collaborated with scholars based in Australia, Finland and Japan. Frequent co-authors include Steven A. Stacker, Marc G. Achen, Megan E. Baldwin, Richard A. Williams, Shin‐Ichi Nishikawa, Remko Prevo, Hajime Kubo, David G. Jackson, Angela A. Vitali and Sally Roufail. Their work appears in journals such as Journal of Biological Chemistry, Clinical & Experimental Metastasis, Assay and Drug Development Technologies, Growth Factors and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.